Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 2.380
-0.030 (-1.24%)
Aug 7, 2026, 4:10 PM AEST
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 447.11 million as of August 7, 2026. Its market cap has decreased by -17.84% in one year.
Market Cap
447.11M
Enterprise Value
739.55M
Revenue
737.49M
Ranking
n/a
PE Ratio
17.10
Stock Price
2.38
ChartMarket Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 447.11M, a decrease of -35.23%. That is a compound annual growth rate of -7.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 441.54M | -15.89% |
| Dec 31, 2025 | 524.97M | -23.31% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 10.99B |
| Integral Diagnostics | 830.65M |
| Healius | 301.35M |
| Monash IVF Group | 272.74M |
| Cryosite | 58.57M |
| Microba Life Sciences | 35.14M |
| Rhythm Biosciences | 32.56M |
| INOVIQ | 27.45M |